Literature DB >> 10210233

Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days.

J Librero1, S Peiró, R Ordiñana.   

Abstract

This article evaluates the behavior of an adaptation of the Charlson Index (CHI) applied to administrative databases to measure the relationship between chronic comorbidity and the hospital care outcomes of length of stay (LOS), in-hospital mortality, and emergency readmissions at 30 and 365 days. These outcomes were analyzed in 106,673 hospitalization episodes whose records are registered in a minimum basic data set maintained by the public health authorities of the community of Valencia, Spain. The highest comorbidity measured by the CHI was associated with greater LOS and in-hospital mortality and increased readmission at 30 and 365 days. The rate of readmissions at 1 year dropped, however, in the group with the greatest comorbidity, probably owing to an increase in mortality after hospitalization. While comorbidity does appear to increase the risk of adverse outcomes in general and mortality and readmission specifically, the second outcome is only possible if the first has not occurred. For this reason, information and selection biases derived from administrative databases, or from the CHI itself, should be taken into account when using and interpreting the index.

Mesh:

Year:  1999        PMID: 10210233     DOI: 10.1016/s0895-4356(98)00160-7

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  93 in total

1.  Inter-hospital variations in caesarean sections. A risk adjusted comparison in the Valencia public hospitals.

Authors:  J Librero; S Peiró; S M Calderón
Journal:  J Epidemiol Community Health       Date:  2000-08       Impact factor: 3.710

2.  Risk factors for 90-day and 180-day mortality in hospitalised patients with pressure ulcers.

Authors:  Anna Flattau; Arthur E Blank
Journal:  Int Wound J       Date:  2012-06-28       Impact factor: 3.315

3.  Rate, delay and predictors of hepatitis C treatment in British Columbia.

Authors:  Alan Hoi Lun Yau; Terry Lee; Alnoor Ramji; Hin Hin Ko
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04-15

4.  Hospitalised osteoporotic vertebral fractures in Spain: analysis of the national hospital discharge registry.

Authors:  C Bouza; T López; M Palma; J M Amate
Journal:  Osteoporos Int       Date:  2007-01-13       Impact factor: 4.507

5.  Deriving comorbidities from medical records using natural language processing.

Authors:  Hojjat Salmasian; Daniel E Freedberg; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2013-10-31       Impact factor: 4.497

6.  The Effect of Pre-existing Seizure Disorders on Mortality and Hospital Length of Stay Following Burn Injury.

Authors:  Kenisha Atwell; Colleen Bartley; Bruce Cairns; Anthony Charles
Journal:  J Burn Care Res       Date:  2019-10-16       Impact factor: 1.845

7.  Maintaining autonomy despite multimorbidity: self-efficacy and the two faces of social support.

Authors:  Lisa M Warner; Jochen P Ziegelmann; Benjamin Schüz; Susanne Wurm; Clemens Tesch-Römer; Ralf Schwarzer
Journal:  Eur J Ageing       Date:  2011-02-10

8.  Nurses joining family doctors in primary care practices: perceptions of patients with multimorbidity.

Authors:  Martin Fortin; Catherine Hudon; Frances Gallagher; Antoine L Ntetu; Danielle Maltais; Hassan Soubhi
Journal:  BMC Fam Pract       Date:  2010-11-04       Impact factor: 2.497

Review 9.  Interventions for improving outcomes in patients with multimorbidity in primary care and community settings.

Authors:  Susan M Smith; Emma Wallace; Tom O'Dowd; Martin Fortin
Journal:  Cochrane Database Syst Rev       Date:  2016-03-14

10.  In-hospital mortality after stomach cancer surgery in Spain and relationship with hospital volume of interventions.

Authors:  Marisa Baré; Joan Cabrol; Jordi Real; Gemma Navarro; Rafel Campo; Carles Pericay; Antonio Sarría
Journal:  BMC Public Health       Date:  2009-08-27       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.